WallStreetZenWallStreetZen

NASDAQ: ALNY
Alnylam Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Alnylam Pharmaceuticals earnings were $577.2M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest ALNY earnings report on Mar 31, 2026 announced Q1 2026 earnings of $206.0M, up 10.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ALNY reported annual earnings of $313.7M, with -212.8% growth. The next ALNY earnings date is Jul 30, 2026.

ALNY earnings history

Current Revenue
$4.3B
Current Earnings
$577.2M
Current Profit Margin
13.5%

ALNY Return on Equity

Current Company
98.3%
Current Industry
-142.1%
Current Market
14.1%
ALNY's Return on Equity (98.3%)... subscribe to Premium to read more.
High Return on Equity Performance

ALNY Return on Assets

Current Company
11.8%
Current Industry
-13.5%
ALNY is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ALNY announces earnings.

ALNY Return on Capital Employed

Current Company
23.01%
Current Industry
-9.4%
ALNY has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ALNY vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ALNY$924.47M$577.22MN/A$4.36
RVMD-$1.32B-$1.37BN/A-$7.10
RPRX$1.16B$827.29M+4.95%$1.91
ONC$902.16M$513.02MN/A$0.36
ARGX$1.51B$1.49B+71.03%$24.23
View Top Biotech Stocks

ALNY earnings dates

Next earnings date
Jul 30, 2026

Alnylam Pharmaceuticals Earnings Reports & History FAQ

What were Alnylam Pharmaceuticals's earnings last quarter?

Alnylam Pharmaceuticals (NASDAQ: ALNY) reported Q1 2026 earnings per share (EPS) of $1.55, up 1,207.14% year over year. Total ALNY earnings for the quarter were $205.99 million. In the same quarter last year, Alnylam Pharmaceuticals's earnings per share (EPS) was -$0.14.

If you're new to stock investing, here's how to buy Alnylam Pharmaceuticals stock.

When does Alnylam Pharmaceuticals report earnings?

The next ALNY earnings call is Invalid Date. Add ALNY to your watchlist to be reminded of Alnylam Pharmaceuticals's next earnings date.

Is Alnylam Pharmaceuticals profitable or losing money?

As of the last Alnylam Pharmaceuticals earnings report, Alnylam Pharmaceuticals is currently profitable. Alnylam Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $577.22 million, a 350.45% decrease year over year.

What was ALNY's earnings growth in the past year?

As of Alnylam Pharmaceuticals's earnings date in Q2 2026, Alnylam Pharmaceuticals's earnings has grown year over year. ALNY earnings in the past year totalled $577.22 million.

What are Alnylam Pharmaceuticals's earnings expectations?

The current EPS estimate for Alnylam Pharmaceuticals's earnings report in Invalid Date is $2.17.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.